Generic Name | Dosage Form | Strength | MA Status |
Anastrazol | Tablets | 1 mg | ES |
Bortezomib* | Lyophilised Injection | 3.5 mg | Under approval |
Docetaxel | Injection | 20 mg/ ml - 1 ml, 4 ml, 8 ml | Under approval |
Doxorubicin HCl | Injection | 2 mg/ml - 2 ml, 5 ml | DE |
Epirubicin HCl | Injection | 2 mg/ml - 5 ml, 10 ml, 25 ml, 100 ml | DE |
Exemestane | Tablets | 25 mg | ES |
5-Flu | Injection | 50 mg /ml - 5ml, 10 ml, 20 ml, 30 ml | DE |
Gemcitabine HCl | Lyophilised Injection | 200 mg , 1 g | DE |
Imatinib | Capsules | 100 mg , 400 mg | ES |
Irinotecan HCl | Injection | 20 mg/ ml - 2ml, 5 ml, 15 ml | DE |
Letrozole | Tablets | 2.5 mg | ES |
Methotrexate | Injection | 10 mg, 50 mg, 500 mg, 5000 mg | DE |
Oxaliplatin | Injection | 5 mg/ml - 10 ml, 20 ml, 30 ml | DE |
Paclitaxel | Injection | 6mg/ml - 30 mg, 100 mg, 150mg, 300 mg | DE |
Pemetrexed* | Injection | 25 mg/ml - 500 mg | Under approval |
Topotecan | Injection | 1 mg ,4 mg | ES |
Zoledronic Acid | Injection | 0,8 mg/ml - 5 ml | ES, DE |
If you cannot find a specific product, you are welcome to Contact us
All transactions are carried out in conformity with patent laws applicable in the user country.
Responsibility with respect to third parties patent rights in a specific country lies exclusively with the buyer.